C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2002
11/14/2002	US20020170087 Transcriptional regulator nucleic acids, polypeptides and methods of use thereof
11/14/2002	US20020170086 Fructan biosynthetic enzymes
11/14/2002	US20020170085 Methyl CpG binding domain nucleic acids from maize
11/14/2002	US20020170084 Process for obtaining plant dna fragment and use thereof
11/14/2002	US20020170083 Process for preparing an anti-oxidant
11/14/2002	US20020170082 Genetically engineered plants for use as tools in the propagation of preferential plants in agriculture
11/14/2002	US20020170081 Transgenic animal for use in the diagnosis, evaluation and treatment of tension
11/14/2002	US20020170080 Animal model for use in the evaluation and treatment of atherosclerosis
11/14/2002	US20020170078 Calcineurin-related transgenic mammals, compositions and methods
11/14/2002	US20020170076 Use of flp recombinase in mice
11/14/2002	US20020170075 Animal model for use in the diagnosis and treatment of anxiety and depression
11/14/2002	US20020169309 Mutation detection method
11/14/2002	US20020169308 Nucleotide sequences coding membrane protein for use in the human diagnostics and therapeutics
11/14/2002	US20020169307 Transgenic mice containing LPR5 gene disruptions
11/14/2002	US20020169306 Paramyxoviral vectro for use as diagnostic tools in genetic engineering
11/14/2002	US20020169305 Nucleotide sequences coding polypeptide for use in the treatment and prevention of malaria
11/14/2002	US20020169304 Nucleotide sequences coding polypeptide for use in the classification, diagnosis, prevention and treatment of downe's syndrome and alzheimers's diseases
11/14/2002	US20020169301 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cell proliferative disorders
11/14/2002	US20020169299 Gene for identifying individuals with familial dysautonomia
11/14/2002	US20020169298 Methods and means for producing barley yellow dwarf virus resistant cereal plants
11/14/2002	US20020169297 Genetic insulator for preventing influence by another gene promoter
11/14/2002	US20020169295 Nucleotide sequences coding protein for use in the treatment, diagnosis and prevention of tumors and inflammatory bowel disease
11/14/2002	US20020169292 Human glycoprotein hormone for use in the prevention and treatment of metabolic and sexual disorders
11/14/2002	US20020169291 Interleukin-18 mutants, their production and use
11/14/2002	US20020169287 Nucleotide sequences coding polypeptide for use in the treatment of eating, dieteticad energy disorders
11/14/2002	US20020169137 Preventing or inhibiting pathological beta-amyloid plaque formation in conditions such as Alzheimer's disease
11/14/2002	US20020169133 Treatment of diseases characterized by excessive deposits of fibrillar interstitial collagens that are resistant to proteolyic degradation thus leading to symptoms of fibrosis
11/14/2002	US20020169132 Polypeptides
11/14/2002	US20020169122 Chondrogenic potential of human bone marrow-derived CD105+ cells by BMP
11/14/2002	US20020169118 TNF receptors, TNF binding proteins and DNAs coding for them
11/14/2002	US20020169117 (RANK); RANK is a member of the TNF superfamily; used to regulate an immune response
11/14/2002	US20020169108 Identifying compounds capable of inhibiting fibronectin-mediated processes, by determining whether a candidate compound binds to a fibronectin Type III polypeptide; administering human uteroglobin
11/14/2002	US20020169106 Administering an OB-cadherin CAR (cell adhesion recognition) sequence
11/14/2002	US20020168771 Expression vcetor for use as tool in genetic engineering
11/14/2002	US20020168769 Nucleotide sequences for use tools in generating genetic engineered plants
11/14/2002	US20020168763 Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same
11/14/2002	US20020168762 B7-H3 and B7-H4, novel immunoregulatory molecules
11/14/2002	US20020168760 Retroviral vector particle for use as tool in genetic engineering
11/14/2002	US20020168757 Test device and method of making same
11/14/2002	US20020168754 Nucleotide sequences coding polypeptides for use in the treatment of gastric, testicular, retinal, nervous system and immunological disorders
11/14/2002	US20020168751 Nucleotide sequences coding polypeptides for use in the treatment of textiles, laundering detergent and in pulp and papermaking
11/14/2002	US20020168750 Glucocerebrosidase for use in the treatment of bone disorders, gaucher's disease, thrombocytopenia and anemia
11/14/2002	US20020168749 Nucleotide sequences coding polypeptide for use in the treatment and prevention of wounds, angiogenesis, restenosis, atherosclerosis, inflammation, nervous system disorders and cancer
11/14/2002	US20020168745 Transacylases of the paclitaxel biosynthetic pathway
11/14/2002	US20020168744 Amino acid sequence
11/14/2002	US20020168740 Kinase for use in the treatment of inflammation, viral infection, cancer, sepsis, psoriasis and restenosis
11/14/2002	US20020168738 Dna fragment carrying toluene monooxygenase gene, recombinant plasmid, transformed microorganism, method for degrading chlorinated aliphatic hydrocarbon compounds and aromatic compounds, and method for environmental remediation
11/14/2002	US20020168737 Compound for use in the treatment of cancer
11/14/2002	US20020168736 Nucleotide sequences coding protein for use in the treatment of immunological disorders
11/14/2002	US20020168735 Protein for use in the prevention of fungal infection
11/14/2002	US20020168734 Rapid thermal cycle processing methods and apparatus
11/14/2002	US20020168732 Fermentative generation of amino acid for use in human foods, nutrients and medicine; obtain corynefrom bacteria, transform with nucleotide sequences coding amino acids, express, isolate preferential amino acids
11/14/2002	US20020168730 Epoxidation of a polyketide; obtain genetically engineered cell, incubate with chemical intermediate, epoxide or hydroxide, recover modified polyketide
11/14/2002	US20020168728 Generation preferential proteins; obtain gram-negative prokaryotic cell, transform with nucleotide sequences coding protein, culture, recover protein
11/14/2002	US20020168726 Bacterial antigens and vaccine compositions
11/14/2002	US20020168724 Nucleotide sequences coding polypeptide for use in the treatment of ataxia, alzheimer's, parkinson's, learning defects, nervous system, epilepsy and stroke disorders
11/14/2002	US20020168723 Nucleotide sequences coding protein for use in the treatment of nervous system disorders
11/14/2002	US20020168721 TSG-like gene
11/14/2002	US20020168719 Nucleotide sequences coding proteins for use in the treatment autoimmune and immunological diseases
11/14/2002	US20020168716 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of tumors, immunological, autoimmune, skin, viral, bone, nervous system and inflammatory disorders
11/14/2002	US20020168715 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/14/2002	US20020168714 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches
11/14/2002	US20020168712 Molecules designated LDCAM
11/14/2002	US20020168711 Nucleic acids, proteins, and antibodies
11/14/2002	US20020168710 Anticancer agents; cardiovascular disorders; anticholesterol agents
11/14/2002	US20020168709 Adjustment of gene expression
11/14/2002	US20020168708 Nucleotide sequences coding polypeptide for use in the treatment of parkinson's, chronic obstructive airways, irritable bowel syndrome, muscle and urogenital disorders
11/14/2002	US20020168707 Genetic engineering; plasmids
11/14/2002	US20020168706 Improved in vitro synthesis system
11/14/2002	US20020168705 Generate protein for X-ray crystallographic analysis; obtain cell extract, incubate with protein synthesis mixture and label, detect signal from preferential protein
11/14/2002	US20020168703 Process for the manufacture of carotenoids and biologically useful materials thereof
11/14/2002	US20020168702 Isolating cells expressing secreted proteins
11/14/2002	US20020168695 Detecting cell proliferative disorder in humans; obtain tissue sample, incubate with probe, detect signal from tissue sample, signal indicates cancer
11/14/2002	US20020168694 Maintaining stem cells of flies; obtain cells, activate signal transduction, propagate and culture cells
11/14/2002	US20020168690 Peptide for use in the treatment of arthritis
11/14/2002	US20020168686 Evaluating activity of proteins; obtain protein, incubate with modulators, generate activity spectrum, classify protein
11/14/2002	US20020168685 Covalent chemical inducers of protein dimerization and their uses in high throughput binding screens
11/14/2002	US20020168684 Generating preferential immunoglobulins; obtain peptide library, immunize cells, isolate anitgen, purify immunoglobulin
11/14/2002	US20020168683 Human pellino polypeptides
11/14/2002	US20020168681 Kit for use in the detection of antibiotics in sample
11/14/2002	US20020168680 Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases
11/14/2002	US20020168676 Method of synthesizing nucleic acid
11/14/2002	US20020168674 Amplifying and isolating preferential nucleotide sequences; obtain preferential nucleotide sequence library, incubate with primers, amplify nucleotide sequences, digest, recover preferential nucleotide sequences
11/14/2002	US20020168673 Mitofusins, Fzo homologs and functional derivatives thereof
11/14/2002	US20020168672 Nucleotide sequences coding proteins for use in the treatment of tumors
11/14/2002	US20020168668 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of neovascularization, cardiovascular, endothelial, kidney, lung, nervous system, pain and metabolic disorders
11/14/2002	US20020168657 Rare event detection system
11/14/2002	US20020168650 Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
11/14/2002	US20020168649 Methods and compositions for screening for modulators of IgE synthesis, secretion and switch rearrangement
11/14/2002	US20020168648 Detecionand determinationof preferential nucleotide sequences; generate microarrays, incubate with preferential nucleotide sequence, expose to probe, measure fluorescent intensity of sample, compare to control, determine nucleotide sequence
11/14/2002	US20020168647 Compositions and methods for the therapy and diagnosis of head and neck cancer
11/14/2002	US20020168646 Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof
11/14/2002	US20020168643 Devices and methods for simultaneous separation and purification of molecular samples
11/14/2002	US20020168640 Microarrays for use in the detection of preferential particles in sample
11/14/2002	US20020168635 Nucleotide sequences coding polypeptides for use in screening modulators of taste
11/14/2002	US20020168634 Detecting genes associated with cell propagation; generate library of preferential cell, incubate with grid, mutagenize, propagate, harvest, extract and isolate nucleotide sequences, incubate with probes, detect pattern, compare to control
11/14/2002	US20020168633 Nucleotide fragment of the 23s rna of the genus chlamydia, use as a probe, primer, and in a reagent and a detection procedure
11/14/2002	US20020168631 Random gene unidirectional antisense library
11/14/2002	US20020168626 Using probes for the detection of preferential viral nucleotide sequences in sample; obtain nucleotide sequences, incubate with probes, detect viral nucleotide sequences
11/14/2002	US20020168623 Compositions and methods for induction of proteins involved in xenobiotic metabolism

1 ... 2661 2662 2663 2664 2665 2666 2667 2668 2669 2670 2671 2672 2673 2674 2675 2676 2677 2678 2679 2680 2681 ... 4023